Skip to main content

Table 2 Vaccine examples showing decreased seroconversion in the elderly

From: Should we vaccinate the better seroconverters or the most vulnerable? Game changing insights for COVID-19 vaccine prioritization policies

Vaccine Authors [reference number in text] Title
Influenza Goodwin et al. [20] Antibody response to influenza vaccination in the elderly: a quantitative review
Meng et al. [21] Immunogenicity of influenza vaccine in elderly people: a systematic review and meta-analysis of randomized controlled trials, and its association with real-world effectiveness
Zhang et al. [22] Immunogenicity of H5N1 influenza vaccines in elderly adults: a systematic review and meta-analysis
Yao et al. [23] Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults
Hepatitis B Havlichek et al. [25] Age-related hepatitis B seroconversion rates in health care workers
Rabies Ceddia et al. [26] Antibody response to rabies vaccine prepared in tissue cultures of human diploid cells and inactivated, evaluated in different classes of age
Mastroeni et al. [27] Immune response of the elderly to rabies vaccines
Japanese encephalitis virus Wagner et al. [29] Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules
Meningitis King et al. [30] Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children
de Costa & Martins Carlos Klein [31] Evaluation of the protective efficacy of an antimeningococcal vaccine for serogroups B and C Neisseria meningitidis infections in Brazil, 1990/92
Espín Ríos et al. [32] Seroconversion and duration of immunity after vaccination against group C meningococcal infection in young children
Hepatitis A Nalin et al. [33] Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview
Varicella-zoster André et al. [34] Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings
Pertussis Nader et al. [35] Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine